Keck Medical Center of USC

Los Angeles, California 90089

10 studies enrolling now · 52 studies all time

What they study most

Acute Kidney Injury, Allografts, Antibody-mediated Rejection, Antibody-mediated Rejection in Kidney Transplant, Aorta, Lesion, Aorta; Lesion, Aortic Aneurysm, Thoracic, Aortic Arch Aneurysm, Aortic Arch Dissection, Ascites, Autoimmune Hepatitis, BK Virus Infection

Studies at this site

• Telerehabilitation In The Home After Stroke — Recruiting now
• GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study — Recruiting now
• Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis — Recruiting now
• Prophylactic Reinforcement of Ventral Abdominal Incisions Trial — Recruiting now
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States — Recruiting now
• The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion — Recruiting now
• IMPRoving Outcomes in Vascular DisEase - Aortic Dissection — Recruiting now
• Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) — Recruiting now
• Smart Boot Use to Measure Offloading Adherence — Recruiting now
• Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials — Recruiting now
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). — Running, not enrolling
• Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) — Running, not enrolling
• Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms — Running, not enrolling
• Alleviant ALLAY-HFrEF Study — Enrolling by invitation
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 — Running, not enrolling
• Molecular Assessment and Profiling of Liver Transplant Recipients — Running, not enrolling
• Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE) — APPROVED_FOR_MARKETING
• LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm — Stopped early
• Liver Cirrhosis Network Cohort Study — Running, not enrolling
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• Reducing Lung CongestIon Symptoms in Advanced Heart Failure — Running, not enrolling
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Stress Radiography for Pelvic Ring Injuries — Completed
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 — Running, not enrolling
• To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF — Completed
• USC and Bodyport Remote Heart Failure Management Study — Completed
• A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant — Completed
• Performance and Safety of Exufiber Ag+ and Exufiber on Partial Thickness Burns — Running, not enrolling
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• ACCEL Absorbable Hemostat — Status unconfirmed
• The Impact of Diabetes on REvascularization — Completed
• Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia — Completed
• A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV — Status unconfirmed
• A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH — Stopped early
• Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection — Completed
• Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia — Completed
• Efficacy of a Sleep Hygiene Toolkit for Patients in ARU — Completed
• LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy — Completed
• Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management — Completed
• The MOTS (Medication Overuse Treatment Strategy) Trial — Completed
• Post Approval Study of the remedē System — Completed
• Beraprost-314d Added-on to Tyvaso® (BEAT) — Completed
• Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing — Completed
• Aquaresis Utility for Hyponatremic Acute Heart Failure Study — Completed
• A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection — Completed